HOLLYSYS AUTOMATION TECHNOLOGIES LTD COM Stock (NASDAQ: HOLI)

HOLLYSYS AUTOMATION TECHNOLOGIES LTD COM (NASDAQ:HOLI) Stock, Quote.Headers.trade-ideas

Hollysys Automation Tech

Movers

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

Hollsys Automation Technologies INTERNATIONAL

HOLI

NICE

Top 5 Tech Stocks That Could Lead To Your Biggest Gains This Month

Penny Stocks

Small Cap

Intraday Update

AAOI

ABSI

ADEX

ARBB

ASST

AWIN

BACK

BNZI

BTCT

CVRX

DERM

ENLV

FPAY

FUSN

GMBL

GRCL

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

LDTC

MIST

NDRA

NEOV

NXTP

ONCT

PSNY

RYZB

SGHT

SNCE

SNTG

SSYS

STBX

SXTP

TURB

TUYA

VLCN

VRNA

WORX

ZJYL

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion.

RayzeBio shares gained 100% to $61.38 on Tuesday.

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Mid Cap

Asset Sales

Hollysys Automation Technologies Ltd (NASDAQ: HOLI) shares are trading higher today as the company got an increased acquisition offer from a buyer Consortium led by 

Dazheng-Led Consortium Raises Hollysys Automation Acquisition Bid to $1.8B, Offers 9% Increase

HOLLYSYS AUTOMATION TECHNOLOGIES LTD COM

HOLIDAY ISLAND HLDGS INC by Holiday Island Holdings, Inc.

Holiday Island Holdings Inc

HOLISTA COLLTECH LTD ORD by Holista Colltech Ltd.

Holista CollTech Ltd

HOLISTIC ASSET FINANCE GR by Holistic Asset Finance Group Co., Ltd.

Holistic Asset Finance Group Co Ltd

Hollysys Automation Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLI#NASDAQ">HOLI</a>) ("Hollysys" or the "Company") today announced that it expects to complete its merger transaction with a buyer controlled by Ascendent Capital Partners as soon as July 25, 2024.

Hollysys Expected Completion Date As Soon As July 25, 2024 For Merger Transaction With Ascendent Capital Partners

Hollysys Automation Technologies Obtained PRC Approvals Required To Be Optioned By Buyer To Complete Merger Transaction

WIIM

Downgrades

Analyst Ratings

Hollysys shares are trading higher after Ascendent Capital Partners said its affiliate, Superior Technologies Holding Limited, obtained all PRC approvals to complete the Merger.

Ascendent Capital Partners, In Amended 13D Filing, Said Affiliate Superior Technologies Received PRC Approvals to Complete Merger With Hollysys Automation Technologies

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">DoubleVerify Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>)</h3>
<ul>
<li>On May 16, DoubleVerify announced a $150 million share repurchase program. The company's stock fell around 38% over the past month and has a <a href="https://www.benzinga.com/quote/DV">52-week low of $17.74</a>.</li>
<li>RSI Value: 24.25</li>
<li>DV Price Action: Shares of DoubleVerify rose 0.7% to close at $18.94 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">NICE Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On May 16, NICE reported upbeat earnings for its first quarter and issued second-quarter adjusted revenue guidance with its midpoint below estimates. "We are pleased to start the year with positive momentum, evidenced by a robust performance across the board, while continuing to outpace the industry," said Barak Eilam, CEO, NICE. The company's stock fell around 7% over the past five days. It <a href="https://www.benzinga.com/quote/NICE">has a 52-week low </a> of $149.54.</li>
<li>RSI Value: 29.06</li>
<li>NICE Price Action: Shares of NICE fell 1.6% to close at $196.58 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Hollysys Automation Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLI#NASDAQ">HOLI</a>)</h3>
<ul>
<li>On May 16, Hollysys Automation Tech posted an increase in quarterly sales. The company's stock fell around 9% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/HOLI">low of $15.60</a>.</li>
<li>RSI Value: 22.24</li>
<li>HOLI Price Action: Shares of Hollysys Automation fell 0.4% to close at $22.17 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">DXC Technology Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>)</h3>
<ul>
<li>On May 17, DXC Technology reported its fourth-quarter financial results. The company reported quarterly earnings of 97 cents per share which beat the analyst consensus estimate of 83 cents by 16.87%. DXC Technology sees fiscal year 2025 adjusted earnings of between $2.50 and $3.00 per share, versus the $3.49 estimate, and full-year revenue in a range of $12.67 billion to $12.95 billion, versus the $13.19 billion estimate. The company's shares lost around 17% over the past five days. The company's 52-week low is $15.45.</li>
<li>RSI Value: 28.94</li>
<li>DXC Price Action: Shares of DXC Technology gained 3.1% to close at $16.41 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">BlackLine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BL#NASDAQ">BL</a>)</h3>
<ul>
<li>On May 22, BlackLine announced upsize and pricing of offering of $600,000,000 of convertible senior notes. The company's shares fell around 12% over the past five days. The company <a href="https://www.benzinga.com/quote/BL">has a 52-week low</a> of $47.26.</li>
<li>RSI Value: 27.85</li>
<li>BL Price Action: Shares of BlackLine fell 1.2% to close at $52.02 on Wednesday.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/24/05/38978690/nvidia-bjs-wholesale-club-and-3-stocks-to-watch-heading-into-thursday">Nvidia, BJ&#8217;s Wholesale Club And 3 Stocks To Watch Heading Into Thursday</a>

Hollysys Automation Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLI#NASDAQ">HOLI</a>) ("Hollysys" or the "Company") has been informed by its Chief Executive Officer, Dr. Changli Wang, that his recent sale of Company shares was made solely for his own personal financial planning needs.
Dr. Wang has informed the Company that following the sale, he holds approximately 80% of his pre-sale holdings in the Company. As the share sale was a personal decision, it does not affect the Company's going private transaction or operational plans. Dr. Wang has informed the Company that he does not intend to sell any further shares in the Company before the closing of the going private transaction with Ascendent Capital Partners ("ACP").
The Company's management, including Dr. Wang, is committed to work towards the satisfaction of the closing conditions of the going private transaction by the parties in accordance with the merger agreement.

Insider Trades

Hollysys CEO Changli Wang Says Recent Sale Of Shares Was Made Solely For His Own Personal Financial Planning Needs, Following The Sale, He Holds ~80% Of His Pre-Sale Holdings

Hollysys Automation Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLI#NASDAQ">HOLI</a>) reported quarterly Adj earnings of $0.07 per share. This is a 65 percent decrease over earnings of $0.20 per share from the same period last year. The company reported $173.47 million in sales this quarter. This is a 3.48 percent increase over sales of $167.64 million the same period last year.

Earnings

Hollysys Automation Tech Q3 Adj EPS $0.07 Down From $0.20 YoY, Sales $173.47M Up From $167.64M YoY

Hollysys Automation Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLI#NASDAQ">HOLI</a>) reported quarterly earnings of $0.23 per share. This is a 71.25 percent decrease over earnings of $0.80 per share from the same period last year. The company reported $223.72 million in sales this quarter. This is a 8.58 percent decrease over sales of $244.73 million the same period last year.

Hollysys Automation Tech Q2 EPS $0.23 Down From $0.80 YoY, Sales $223.72M Down From $244.73M YoY

<ul>
<li>Approximately 86.94% of the shareholders who voted at the shareholders meeting approved Ascendent's acquisition proposal; Approximately 76.95% of shareholders voted, underlining the competitive value that has been offered to them.</li>
<li>Ascendent is committed to securing regulatory approvals and closing the acquisition expeditiously.</li>
</ul>
HONG KONG, Feb. 8, 2024 /PRNewswire/ -- Ascendent Capital Partners ("Ascendent"), a private equity investment management firm managing assets for global institutional investors, is pleased to note that Hollysys Automation Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLI#NASDAQ">HOLI</a>)&nbsp;("Hollysys" or the "Company") has announced the voting results of the Company's Extraordinary General Meeting ("EGM") held today. The EGM concluded with the overwhelming majority of Hollysys shareholders approving all resolutions, including the resolution pursuant to which Ascendent will acquire all outstanding shares of Hollysys that it does not currently own for US$26.50 per share in cash.
Leon Meng, Chairman and CEO of Ascendent, commented: "Today marks an important milestone for Hollysys, its investors, management, and staff. Ascendent, with our highest standards of corporate governance, applauds the Special Committee for conducting a transparent, thorough and robust sale process. We also want to thank Hollysys shareholders for their strong support and will work towards securing the required regulatory approvals expeditiously. Today's vote demonstrates that with a solid company in a transparent process, significant buyouts can still be done with the right private equity firms, even in this challenging macro environment and region."
In addition, shareholders at the EGM authorized and approved the appointment of each of Guanghua Miao, Ding Wei and Dennis Demiao Zhu to the board of directors of the Company.

Ascendent Wins Shareholder Support To Acquire All Outstanding Shares Of Hollysys Automation Technologies, That It Does Not Currently Own For $26.50 Per Share In Cash

Hollysys Announces Shareholder Approval Of Merger Agreement With Ascendent, Once Completed Company Says It's Ordinary Shares Would No Longer Be Listed Or Traded

Buyer Consortium will remain committed to acquiring Hollysys at US$29.50 per share after the proposed Ascendent transaction is rejected by shareholders
Buyer Consortium's offer provides more closing certainty than the proposed Ascendent transaction
Urges shareholders to vote AGAINST the proposed Ascendent transaction
Buyer Consortium ("the Consortium") led by Dazheng Group Acquisition Limited ("Dazheng Group") today issued the following statement reaffirming the merits of its offer to acquire Hollysys Automation Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLI#NASDAQ">HOLI</a>) ("Hollysys").
The Buyer Consortium, led by Dazheng Group, remains extremely motivated to acquire Hollysys at US$29.50 per share. This offer represents a significantly greater value proposition for Hollysys shareholders, providing an 11.3% premium to the Ascendant Capital offer. The Consortium emphasizes to Hollysys shareholders its commitment to acquire Hollysys at US$29.50 per share will remain unchanged by fluctuations in the share price of Hollysys, market conditions, or if the proposed Ascendent transaction is rejected by shareholders at the upcoming Extraordinary General Meeting ("EGM") on February 8, 2024.
The Consortium's offer has enhanced closing certainty relative to the Ascendent offer and is backed by financing ABOVE industry standards. The Consortium has secured a debt commitment letter for US$1.05 billion from a reputable PRC-headquartered bank's Hong Kong branch, which is the same bank that issued a debt commitment letter to Ascendent Capital. Additionally, the Consortium has successfully secured equity commitments totaling US$800 million from Dazheng Group Acquisition Limited and TFI Asset Management Limited. The commitment from Dazheng Group Acquisition Limited is robustly supported by back-to-back equity commitment letters, which have been formally executed by three sponsors as of January 25, 2024. Each sponsor has demonstrated their ability to fulfill their financial commitments by supplying robust proof of funding. This includes bank statements detailing offshore fund balances and/or documentation confirming available funds, all of which have been either officially stamped by the bank or signed by an authorized bank representative. The Consortium has adhered to all reasonable demands of the Special Committee throughout the entirety of this negotiation process, resulting in financing commitments beyond industry standards and, to the Consortium's knowledge, beyond those of Ascendent Capital. Notably, Hollysys has not detailed in its proxy statement the basis on which the Special Committee validated Ascendent Capital's financial capacity, aside from the filing of signed commitment letters.
Beyond being backed by financing above industry standards and requiring less or no regulatory approvals compared to Ascendent transaction, the Consortium highlights it is committed to closing its proposed transaction unless more than 20% of Hollysys shareholders exercise dissenting and appraisal rights under Section 179 of the British Virgin Islands ("BVI") Business Companies Act. This threshold is double that of Ascendent's conditions and reflects the Consortium's confidence in the merits of its proposed deal and dedication to closing the transaction.
The Consortium wishes to highlight to the shareholders that, despite facing challenges in our dealings with the Special Committee, the Special Committee acknowledged in the proxy statement supplement dated January 31, 2024, that negotiations on transaction documents between Hollysys and the Consortium began on January 28, 2024. This acknowledgment implies the Special Committee's recognition of our proposal as superior or reasonably likely to be superior, because otherwise, the Special Committee is prohibited from negotiating documents with the Consortium under the signed merger agreement. Unfortunately, the Special Committee set a stringent deadline of January 29, 2024, for finalizing all aspects of the deal, without considering the possibility of recommending an adjournment of the EGM to shareholders. The Consortium maintains that in order to fully meet their fiduciary duties as dictated by BVI law, the Special Committee should have recommended to the shareholders the adjournment of the EGM. Without the presentation of this option to the shareholders, the shareholders' sole recourse to secure the benefit from an exit at $29.50 per share is to vote AGAINST the Ascendent transaction. Furthermore, should there be any recommendation from the Board or Chairman of the EGM to adjourn the EGM, and such adjournment is approved, the Consortium urges shareholders to require the Board to convene a shareholders meeting to be held at the same time as the adjourned EGM and allow shareholders to consider the Consortium's proposal.
Leading Proxy Advisors, Institutional Shareholder Services ("ISS") and Glass Lewis have recently recommended shareholders vote AGAINST the potential transaction with Ascendent Capital. Both proxy advisors had the following to say in conclusion of its research concerning the sales process and the behavior of the Special Committee:
<ul>
<li>"Given the questionable effort to maximize price, the unreasonably high standard to which Ascendent's main competitor has been held, and the inexplicably truncated process, votes against the proposed transaction are warranted."</li>
<li>"When placed in full context, we believe there is vanishingly small cause for shareholders to endorse an arrangement derived from what we consider to be a flawed, low accountability process seemingly engineered in its later stages to blunt the shareholder franchise and trade potentially materially greater value for deference to a deal with Ascendent on an accelerated basis."</li>
</ul>
Hollysys shareholders have a better alternative than what the Board is currently presenting them. The Consortium urges shareholders to not leave an extra 11.3% on the table by voting AGAINST the proposed Ascendent transaction at the upcoming EGM on February 8, 2024.
The Consortium wishes to remind shareholders interested in exercising dissenting and appraisal rights under Section 179 of the BVI Business Companies Act that they must NOT VOTE FOR the Ascendent transaction. This is essential to safeguard shareholders' appraisal rights, an important aspect notably absent from pages 112-113 of Hollysys's proxy statement in the discussion on "Dissenters' Rights." Furthermore, the Consortium emphasizes that should the Ascendent transaction be rejected by the shareholders, Hollysys will not be required to pay any termination fee to Ascendent as per the terms of the existing merger agreement. Thus, the collective decision of shareholders to vote AGAINST the Ascendent transaction will not adversely affect Hollysys. Instead, it will safeguard a valuable opportunity for every shareholder to achieve an exit at $29.50 per share, following the conversion of the Consortium's offer into a signed merger agreement, which is anticipated to be promptly approved by the shareholders.

Buyer Consortium Led By Dazheng Group Reaffirms Commitment To Acquire Hollysys At $29.50 Per Share

-&nbsp;Special Committee concluded Dazheng proposal was not superior after rigorous negotiations
-&nbsp;Dazheng was unable to provide sufficient assurances around equity financing and last-minute introduction of yet another new member after multiple changes in its consortium composition raised further questions that could not be resolved&nbsp;
-&nbsp;Special Committee&nbsp;strongly disagrees with flawed ISS and Glass Lewis recommendations: a transparent and well-run process has brought the right outcome for shareholders: the Ascendent deal&nbsp;
-&nbsp;Updated proxy materials detailing engagement with Dazheng in recent weeks will be released shortly

Hollysys Rejects Dazheng Proposal, Citing Financing Concerns And Consortium Instability, Endorses Ascendent Deal

As the go-shop period has ended, the &quot;no-shop&quot; provisions in the merger agreement are now in effect.&nbsp;None of the offers received constitutes or would reasonably be expected to result in a superior proposal

Hollysys Reports End Of "Go-Shop" Period Under Merger Agreement With Ascendent Capital Partners

Shares of RayzeBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ryzb#NASDAQ">RYZB</a>) rose sharply during Tuesday&rsquo;s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion.
RayzeBio shares gained 100% to $61.38 on Tuesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>ARB IOT Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbb#NASDAQ">ARBB</a>) shares rose 270% to $3.4850 after gaining around 18% on Friday.</li>
<li>IMAC Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/back#NASDAQ">BACK</a>) shares jumped 108% to $5.05 after jumping 53% on Friday.</li>
<li>Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iinn#NASDAQ">IINN</a>) jumped 75% to $2.0988 after the company announced 95% accuracy results for HYLA blood sensor.</li>
<li>Gracell Biotechnologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grcl#NASDAQ">GRCL</a>) shares gained 60.3% to $9.92 after AstraZeneca announced plans to buy Gracell Biotechnologies for up to $1.2 billion.</li>
<li>Science 37 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snce#NASDAQ">SNCE</a>) jumped 52% to $6.62. Science 37 Holdings got notification from Nasdaq indicating the company regained compliance with minimum closing bid price requirement for continued listing.</li>
<li>Volcon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) rose 49.8% to $0.1483 after jumping around 24% on Friday.</li>
<li>Sight Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sght#NASDAQ">SGHT</a>) gained 48.9% to $5.42.</li>
<li>AERWINS Technologies Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/awin#NASDAQ">AWIN</a>) gained 36.4% to $0.1637 after the company entered into a letter of intent to form an entity with Helicopter Technology. The company will own 70% and Helicopter Technology will own 30%.</li>
<li>SCWorx Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/worx#NASDAQ">WORX</a>) rose 32% to $2.3349 after the company announced that it signed a definitive agreement and plan of merger with American Environmental Partners.</li>
<li>60 Degrees Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtp#NASDAQ">SXTP</a>) gained 30% to $1.1750 after the company announced IRB approval of its Phase IIA clinical study to evaluate tafenoquine for babesiosis.</li>
<li>Absci Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/absi#NASDAQ">ABSI</a>) jumped 27% to $4.23.</li>
<li>CVRx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvrx#NASDAQ">CVRX</a>) rose 19% to $29.72. CVRx received FDA approval for expanded labeling of barostim.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) gained 15.5% to $3.66.</li>
<li>GigaCloud Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gct#NYSE">GCT</a>) jumped 13.9% to $16.93.</li>
<li>Fusion Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fusn#NASDAQ">FUSN</a>) rose 13.5% to $7.75.</li>
<li>Tuya Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tuya#NYSE">TUYA</a>) gained 11.9% to $2.2950.</li>
<li>Stratasys Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) shares gained 11.1% to $14.57. Stratasys confirmed receipt of unsolicited preliminary proposal from Nano Dimension at $16.50 per share.</li>
<li>Sentage Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) shares gained 10.3% to $1.82 following results for the six months ended June 30, 2023.</li>
<li>Verona Pharma plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrna#NASDAQ">VRNA</a>) rose 10.1% to $19.36.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaoi#NASDAQ">AAOI</a>) gained 9.9% to $22.97.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) rose 9.9% to $9.25 after the company unveiled a new smart EV model over the weekend.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) gained 9.5% to $2.52.</li>
<li>Hollysys Automation Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holi#NASDAQ">HOLI</a>) shares gained 6.7% to $27.24 as the company got an increased acquisition offer from a buyer Consortium led by Dazheng Group Acquisition Limited.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>PARTS iD, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/id#NYSE">ID</a>) shares declined 43.3% to $0.0489 after the company entered into a Credit Agreement with Fifth Star.</li>
<li>Milestone Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mist#NASDAQ">MIST</a>) fell 32.2% to $1.9534 after the company announced that it received a Refusal to File letter from the FDA for the New Drug Application for self-administered etripamil nasal spray for the treatment of paroxysmal supraventricular tachycardia.</li>
<li>Prospector Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ldtc#NASDAQ">LDTC</a>) shares fell 30.3% to $2.9218 after jumping around 77% on Friday.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) shares fell 23.8% to $2.08 after surging over 200% on Friday.</li>
<li>ENDRA Life Sciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ndra#NASDAQ">NDRA</a>) fell 23.6% to $1.91.</li>
<li>Esports Entertainment Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmbl#NASDAQ">GMBL</a>) dipped 23.6% to $5.28.</li>
<li>Banzai International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnzi#NASDAQ">BNZI</a>) declined 20.7% to $2.75.</li>
<li>Adit EdTech Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adex#NASDAQ">ADEX</a>) shares fell 20.6% to $3.9801. Adit EdTech Acquisition announced intention to voluntarily de-list from NYSE American.</li>
<li>Know Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knw#NYSE">KNW</a>) dipped 19.2% to $0.47. Know Labs filed for mixed shelf of up to $18 million.</li>
<li>Turbo Energy, S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/turb#NASDAQ">TURB</a>) fell 19% to $1.23.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stbx#NASDAQ">STBX</a>) declined 16.2% to $0.2599.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) fell 15.7% to $116.94 after jumping 94% on Friday.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zim#NYSE">ZIM</a>) declined 15.2% to $9.82.</li>
<li>Vroom, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrm#NASDAQ">VRM</a>) shares fell 14.5% to $0.6295. Vroom filed a preliminary proxy statement with the SEC regarding a special stockholders&#39; meeting to be held on Feb. 5, 2024 to effect a reverse stock split of the company&#39;s common stock at an exchange ratio between 1-for-35 to 1-for-80.</li>
<li>NeoVolta Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neov#NASDAQ">NEOV</a>) fell 14.4% to $1.54.</li>
<li>Journey Medical Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) dipped 13.8% to $6.86.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) fell 13.4% to $0.6907 after surging 21% on Friday.</li>
<li>Enlivex Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enlv#NASDAQ">ENLV</a>) fell 11% to $2.57.</li>
<li>FlexShopper, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fpay#NASDAQ">FPAY</a>) fell 9.5% to $1.6191.</li>
<li>BTC Digital Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btct#NASDAQ">BTCT</a>) fell 9.3% to $4.08. BTC Digital announced entry into $1.014 million share subscription agreements in connection with private placement of ordinary shares for the issue and sale of 303,497 ordinary shares of the company, par value $0.06 per share.</li>
<li>Oncternal Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onct#NASDAQ">ONCT</a>) fell 8% to $0.55. Oncternal Therapeutics updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed previous CD19 CAR-T treatment.</li>
<li>Gannett Co., Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gci#NYSE">GCI</a>) fell 6.2% to $2.43.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36380862/how-to-earn-500-a-month-from-nike-stock-following-quarterly-report"> How To Earn $500 A Month From Nike Stock Following Quarterly Report</a>

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Hollysys Automation Technologies Ltd&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holi#NASDAQ">HOLI</a>) shares are trading higher today as the company got an increased acquisition offer from a buyer Consortium led by&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/23/12/b36377346/buyer-consortium-led-by-dazheng-group-announces-enhanced-all-cash-proposal-of-us-29-00-per-share-t" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Dazheng Group Acquisition Limited.</a>
The consortium intends to buy HOLI for $29.00 per share or about $1.8 billion in cash.
The acquisition cost represents a 55.5% premium to HOLI&#39;s closing share price of $18.66 on August 23, 2023, and a 40.8% premium to its closing share price of $20.60 on November 3, 2023.&nbsp;
Notably, the new acquisition price represents a 9.4% increase on the consortium&#39;s previous offer of $26.50 per share (November 8, 2023) and represents a 9.4% higher offer price than Ascendent&#39;s competing offer.
The consortium is aiming to engage with HOLI&#39;s Board, conclude the due diligence process, and pen a merger agreement before January 22, 2024.
In October, HOLI announced the formation of a special committee of the board of directors to conduct&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/m-a/23/10/35030573/why-is-hollysys-automation-technologies-stock-trading-higher-monday" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">a formal sale process</a>.&nbsp;
Price Action: HOLI shares are trading higher by 6.19% at $27.10 on the last check Friday.

U.S. stock futures were higher this morning, with the Dow Jones futures gaining more than 40 points on Tuesday.
Shares of Gracell Biotechnologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grcl#NASDAQ">GRCL</a>) shares rose sharply in pre-market trading after AstraZeneca announced plans to buy Gracell Biotechnologies for up to $1.2 billion.
Gracell Biotechnologies shares gained 65.1% to $10.22 in pre-market trading.
Here are some big stocks recording gains in today&rsquo;s pre-market trading session.
<ul>
<li>Manchester United plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/manu#NYSE">MANU</a>) rose 12.2% to $22.25 in pre-market trading. British billionaire Jim Ratcliffe has bought a minority stake in the esteemed football club Manchester United .</li>
<li>Stratasys Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) shares gained 9.8% to $14.40 in pre-market trading. Stratasys confirmed receipt of unsolicited preliminary proposal from Nano Dimension at $16.50 per share.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) shares climbed 7.8% to $35.79 in pre-market trading. The Wall Street Journal reported that Biden administration is exploring raising tariffs on Chinese EVs.</li>
<li>Hollysys Automation Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holi#NASDAQ">HOLI</a>) shares gained 6.2% to $27.10 in pre-market trading. A buyer consortium led by Dazheng Group proposed enhanced $29 per share all-cash offer to acquire Hollysys.</li>
<li>Helmerich &amp; Payne, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hp#NYSE">HP</a>) shares rose 6.5% to $39.00 in pre-market trading.</li>
<li>Altimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alt#NASDAQ">ALT</a>) shares rose 5.4% to $9.78 in pre-market trading after gaining 17% on Friday.</li>
<li>SES AI Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ses#NYSE">SES</a>) shares rose 4.9% to $1.94 in pre-market trading after falling over 7% on Friday.</li>
<li>Canadian Solar Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/csiq#NASDAQ">CSIQ</a>) shares rose 4.4% to $26.53 in pre-market trading.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/12/36380823/tesla-apple-and-3-stocks-to-watch-heading-into-tuesday"> Tesla, Apple And 3 Stocks To Watch Heading Into Tuesday </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

CSIQ

MANU

Gracell Biotechnologies, Stratasys, Hollysys Automation Technologies And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session

<ul>
<li>Enhanced proposal is&nbsp;9.4%&nbsp;higher than the Ascendent Capital offer and is backed by secured financing</li>
<li>Ascendent Capital&#39;s proposal does not represent the best value for shareholders</li>
<li>The Consortium has full confidence that the Hollysys Board will deem its enhanced proposal superior and remains ready to enter into a merger agreement</li>
</ul>

Reported Sunday, Buyer Consortium Led By Dazheng Group Proposes Enhanced $29/Share All-Cash Offer To Acquire Hollysys, Deeming It Superior To Ascendent Capital's Bid

Hollysys Automation Technologies shares are trading higher after the company announced that it reached an agreement to be acquired by Ascendent Capital Partners through an all-cash transaction valued at approximately $1.66 billion.

Hollysys To Be Acquired By Ascendent Capital Partners For $26.50  Per Share In Cash

Reiterates All-Cash Offer of US$26.50 Per Share while Noting Board is Negotiating a Deal without the Support of Shareholders
Special Meeting Must Happen Prior to Definitive Deal, Any Deal Announced Prior to Special Meeting Will Not Carry the Clear Support of Shareholders
Buyer consortium ("the consortium") led by Recco Control Technology Pte. Ltd. ("Recco Control Technology") and Dazheng Group (Hong Kong) Investment Holdings Company Limited ("Dazheng Group") today reiterates its all-cash proposal of US$26.50 per share for Hollysys Automation Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLI#NASDAQ">HOLI</a>) ("Hollysys"). This statement comes amidst an announcement of the board of directors ("Board") of Hollysys that has indicated that the special meeting ("Special Meeting") of shareholders requested by certain shareholders on August 24, 2023 will be held in the week of January 22, 2024 following a persistent campaign by the Board to deny shareholders basic rights. Members of the consortium also include TFI Asset Management Limited, and Great Wall Capital Co., Ltd, who have entered into a memorandum of strategic cooperation with Recco Control Technology and Dazheng Group in connection with the proposed acquisition of Hollysys.
The Board continues to take actions that impede or disregard the basic rights and wishes of the shareholders. Announcing the Special Meeting will be held in the week of January 22, 2024 while indicating that the Board hopes to execute a merger agreement by mid-December 2023 is a direct disregard for what the shareholders want and renders the Special Meeting futile. Shareholders are entitled to choose the board of directors, in whom they have trust and confidence, that they wish to run the sales process and the current Board is denying shareholders this basic right at one of the most important times in the Company's history.
Furthermore, as the leading bidder for Hollysys with a bid of $26.50 per share, we have to wonder if the Board is, at the expense of shareholders, seeking once again to create a situation that is more favorable for a management buyout rather than supporting a higher third party bid. Any attempt by the Board to prematurely seal a deal potentially undermines the maximization of shareholder value.
To ensure the sale process is one that is legitimate and maximizes shareholder value rather than one which favors management, the Board must hold the Special Meeting before any binding agreement is reached.
Advisors
UBS AG Hong Kong Branch1 is serving as financial advisor to leaders of the consortium, Recco Control Technology and Dazheng Group. Sullivan &amp; Cromwell LLP and DLA Piper are United States counsels to the consortium. Conyers Dill &amp; Pearman is advising the consortium on BVI law.

Management

Buyer Consortium Led By Recco Control Technology And Dazheng Group Issues Statement On Hollysys' Announced Special Meeting

Hollysys Undervalued Ahead Of Going Private, But Risks Remain

Hollysys Automation jumps after buyer Ascendent says all China approvals received

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have the biggest pre-market stock movers that traders are going to want to start the week with on Monday morning!



Moving stocks this morning are Roaring Kitty news, a company filing for bankruptcy and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Loop Media (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lptv-stock-quote/">LPTV</a>) stock is rocketing 88% alongside heavy pre-market trading.</li>



<li>Golden Heaven (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdhg-stock-quote/">GDHG</a>) shares are soaring close to 43% with strong early morning trading.</li>



<li>Chewy (NYSE:<a href="https://investorplace.com/stock-quotes/chwy-stock-quote/">CHWY</a>) stock is surging almost 19% as Roaring Kitty <a href="https://www.cnbc.com/2024/07/01/chewy-shares-rally-20percent-after-sec-filing-reveals-roaring-kitty-keith-gill-has-6point6percent-stake.html">takes a stake in the company</a>.</li>



<li>Mesoblast (NASDAQ:<a href="https://investorplace.com/stock-quotes/meso-stock-quote/">MESO</a>) shares are increasing more than 16% on a <a href="https://www.nasdaq.com/press-release/mesoblast-file-biologics-license-application-ryoncilr-fda-approval-next-week-2024-07">new biologics license application</a>.</li>



<li>Barfresh Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/brfh-stock-quote/">BRFH</a>) stock is rising over 16% despite a lack of news this morning.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) shares are gaining nearly 15% with strong pre-market trading.</li>



<li>Incannex Healthcare (NASDAQ:<a href="https://investorplace.com/stock-quotes/ixhl-stock-quote/">IXHL</a>) stock is climbing more than 12% without any clear news today.</li>



<li>Tempus AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/tem-stock-quote/">TEM</a>) shares are getting an over 13% boost <a href="https://www.tradingview.com/news/reuters.com,2024:newsml_L1N3IQ0UH:0-tempus-ai-rallies-in-three-day-recovery-still-below-ipo-price/">with a recent rally</a> after its initial public offering (<a href="https://investorplace.com/stock-quotes/ipo-stock-quote/">IPO</a>) last month.</li>



<li>Lion Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/lghl-stock-quote/">LGHL</a>) stock is jumping more than 13% with heavy early morning trading today.</li>



<li>Hollysys Automation Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/holi-stock-quote/">HOLI</a>) shares are up over 13% without any obvious news this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Delta Apparel (NYSEMKT:<a href="https://investorplace.com/stock-quotes/dla-stock-quote/">DLA</a>) stock is plummeting more than 34% despite no clear news this morning.</li>



<li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/csse-stock-quote/">CSSE</a>) shares are diving over 20% after <a href="https://fortune.com/2024/06/29/redbox-dvd-kiosks-chicken-soup-for-the-soul-chapter-11-bankruptcy-filing/">filing for Chapter 11 bankruptcy</a>.</li>



<li>African Agriculture (NASDAQ:<a href="https://investorplace.com/stock-quotes/aagr-stock-quote/">AAGR</a>) stock is tumbling more than 14% alongside recent volatility.</li>



<li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssep-stock-quote/">CSSEP</a>) shares are taking an over 14% beating with the bankruptcy filing.</li>



<li>Chicken Soup for the Soul Entertainment, Inc. &ndash; 9.50% Notes due 2025 (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssen-stock-quote/">CSSEN</a>) are sliding more than 12% alongside the bankruptcy news.</li>



<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) stock is falling 12% after a Friday rally.</li>



<li>Lakeside (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) shares are dropping over 10% this morning.</li>



<li>Li-Cycle (NYSE:<a href="https://investorplace.com/stock-quotes/licy-stock-quote/">LICY</a>) stock is decreasing more than 10% on an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318425152&amp;type=PDF&amp;symbol=LICY&amp;cdn=adb9d0bf10804596acf67ff3f07cb9bd&amp;companyName=Li-Cycle+Holdings+Corp.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-28">at-market sales agreement</a>.</li>



<li>AgriForce Growing Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/agri-stock-quote/">AGRI</a>) shares are slipping over 10% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318425454&amp;type=PDF&amp;symbol=AGRI&amp;cdn=5153a3d8a3670dcb6c5185b3625a84cd&amp;companyName=AgriFORCE++Growing+Systems+Ltd.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-28">a delisting notice</a>.</li>



<li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) stock closes out our pre-market stock movers down more than 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-1st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Following Wall Street's strong June showing, we're now entering a historically bullish month for the market.

Stocks Mixed As Historically Bullish Month Begins

Hollysys Automation (HOLI) has released an update. Hollysys Automation Technologies Ltd. has announced the near completion of its merger with a buy...

Hollysys Automation Nears Merger Completion

Hollysys Automation ticks higher as buyer gets funding for planned takeover

Hollysys Automation ticks higher as buyer gets funding for planned takeover (update)

Hollysys Automation (HOLI) has released an update. Hollysys Automation Technologies Ltd. is set to finalize its merger with a buyer from Ascendent ...

Hollysys Set for Merger Completion and NASDAQ Delisting

Hollysys expects to complete merger with Ascendent Capital Partners by July 25

Hollysys Automation (HOLI) has released an update. Hollysys Automation Technologies Ltd. has completed a merger with entities affiliated with Ascen...

Hollysys Completes Merger, Ends Public Trading

AAGR

ABBNY

AGRI

BRFH

CHWY

CSSE

CSSEN

CSSEP

GDHG

IONM

IXHL

LGHL

LICY

LPTV

MESO

NUKK

SIEGY

WLGS

Press Releases

Dazheng Group Reaffirms Commitment to Acquire Hollysys at US$29.50 Per Share

Hollysys Announces Shareholder Approval of Merger Agreement with Ascendent

Ascendent Wins Overwhelming Shareholder Support to Acquire Hollysys for US$26.50 Per Share

Hollysys Automation Technologies Reports Unaudited Financial Results for the Second Quarter and the First Half Year Ended December 31, 2023

Hollysys Automation Technologies Reports Unaudited Financial Results for the Third Quarter and the First Nine Months Ended March 31, 2024

Hollysys CEO Informs Company of Recent Share Sales

Hollysys Announces Appointment of New Auditor

Hollysys Announces Completion of Regulatory Review of Merger Transaction

Hollysys Announces Expected Completion Date of Merger Transaction with Ascendent Capital Partners

Hollysys Announces Completion of Merger Transaction with Ascendent Capital Partners

JP Morgan

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

HOLLYSYS AUTOMATION TECHNOLOGIES LTD COM

HOLLYSYS AUTOMATION TECHNOLOGIES LTD COM (HOLI) Forecast

HOLLYSYS AUTOMATION TECHNOLOGIES LTD COM (NASDAQ:HOLI) Stock, Quote.Headers.trade-ideas